Cangrelor Use Patterns and Transition to Oral P2Y(12) Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry

BACKGROUND: In clinical trials, cangrelor has been shown to reduce percutaneous coronary intervention–related ischemic complications without increasing major bleeding. This study was performed to examine cangrelor use and transition to oral P2Y(12) inhibitors in routine clinical practice. METHODS AN...

Descripción completa

Detalles Bibliográficos
Autores principales: Rymer, Jennifer A., Bhatt, Deepak L., Angiolillo, Dominick J., Diaz, Miguel, Garratt, Kirk N., Waksman, Ron, Edwards, Laura, Tasissa, Gudaye, Salahuddin, Khalid, El‐Sabae, Hijrah, Dell’Anna, Carmen, Davidson‐Ray, Linda, Washam, Jeffrey B., Ohman, E. Magnus, Wang, Tracy Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238709/
https://www.ncbi.nlm.nih.gov/pubmed/35621210
http://dx.doi.org/10.1161/JAHA.121.024513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238709/
https://www.ncbi.nlm.nih.gov/pubmed/35621210
http://dx.doi.org/10.1161/JAHA.121.024513

Ejemplares similares